Thyroid hormone is essential for normal human growth, normal brain development and function and for constituitive thermogenesis. Most of the active thyroid hormone, 3,5, 3' triiodothyronine (T3), in intact individuals and all of this in the 2-3% of the U.S. population with hypothyroidism, is generated from thyroxine (T4) by 5' monodeiodination. This reaction is catalyzed by the selenoenzymes, Types 1 and 2 deiodinase (D1 and D2) products of the dio1 and 2 genes respectively. Inactivation of T4 and T3 especially in the brain and feto-placental unit, occurs by 5 deiodination catalyzed by another selenoenzyme, Type 3 deiodinase (D3) as well as by the bifunctional D1. Both D1 and D3 have been cloned and both are regulated positively by T3 at the mRNA level through direct mechanisms which do not require new protein synthesis. These critical enzymes are essential parts of an internal feedback loop acting to maintain T3 homeostasis. They can function independently of the hypothalamic- pituitary axis. This project will analyze the regulation of dio1 and 3 as models of genes directly and positively regulated by T3.
Specific Aim I will explore the mechanism for regulation of the action of TRE2 in the human dio1 gene and determine the mechanism for negative regulation of dio1 expression by T3 in specific cell types. These studies will employ transient expression assays of homologous promoter-reporter constructs with and without co-expressed thyroid hormone receptor (TR) or other transcription factors.
Specific Aim II will delineate the nature of the TR-TRE interaction and how it is affected by T3 using in vivo genomic footprinting of synthetic and endogenous genes by ligation-mediated PCR.
Specific Aim III will focus on the mechanism for regulation of D3 expression by thyroid hormone including cloning of the 5' flanking region, studies of changes in D3 expression in various brain regions with altered thyroid status and iodine deficiency using in situ hybridization and immunohistochemistry, studies in cell culture systems, and in vivo genomic footprinting. By these techniques we will gain new knowledge of how T3 directly regulates the transcription of the genes encoding the enzymes which catalyze essential steps in thyroid hormone activation and inactivation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK044128-07
Application #
2684217
Study Section
Endocrinology Study Section (END)
Program Officer
Margolis, Ronald N
Project Start
1992-01-15
Project End
2001-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
7
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Wassner, Ari J; Jugo, Rebecca H; Dorfman, David M et al. (2017) Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy. Thyroid 27:732-737
Luongo, Cristina; Martin, Cecilia; Vella, Kristen et al. (2015) The selective loss of the type 2 iodothyronine deiodinase in mouse thyrotrophs increases basal TSH but blunts the thyrotropin response to hypothyroidism. Endocrinology 156:745-54
Wittmann, Gábor; Harney, John W; Singru, Praful S et al. (2014) Inflammation-inducible type 2 deiodinase expression in the leptomeninges, choroid plexus, and at brain blood vessels in male rodents. Endocrinology 155:2009-19
Maynard, Michelle A; Marino-Enriquez, Adrian; Fletcher, Jonathan A et al. (2014) Thyroid hormone inactivation in gastrointestinal stromal tumors. N Engl J Med 370:1327-34
Salvatore, Domenico; Simonides, Warner S; Dentice, Monica et al. (2014) Thyroid hormones and skeletal muscle--new insights and potential implications. Nat Rev Endocrinol 10:206-14
Dentice, Monica; Ambrosio, Raffaele; Damiano, Valentina et al. (2014) Intracellular inactivation of thyroid hormone is a survival mechanism for muscle stem cell proliferation and lineage progression. Cell Metab 20:1038-48
Zavacki, Ann Marie; Larsen, P Reed (2013) RTH?, a newly recognized phenotype of the resistance to thyroid hormone (RTH) syndrome in patients with THRA gene mutations. J Clin Endocrinol Metab 98:2684-6
Hong, Eun-Gyoung; Kim, Brian W; Jung, Dae Young et al. (2013) Cardiac expression of human type 2 iodothyronine deiodinase increases glucose metabolism and protects against doxorubicin-induced cardiac dysfunction in male mice. Endocrinology 154:3937-46
Dentice, Monica; Marsili, Alessandro; Zavacki, Annmarie et al. (2013) The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation. Biochim Biophys Acta 1830:3937-45
Larsen, P Reed; Zavacki, Ann Marie (2012) The role of the iodothyronine deiodinases in the physiology and pathophysiology of thyroid hormone action. Eur Thyroid J 1:232-242

Showing the most recent 10 out of 54 publications